175 related articles for article (PubMed ID: 23982754)
1. Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.
Nadalutti CA; Korponay-Szabo IR; Kaukinen K; Griffin M; Mäki M; Lindfors K
Cell Mol Life Sci; 2014 Apr; 71(7):1315-26. PubMed ID: 23982754
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.
Antonella Nadalutti C; Korponay-Szabo IR; Kaukinen K; Wang Z; Griffin M; Mäki M; Lindfors K
PLoS One; 2013; 8(10):e77277. PubMed ID: 24130874
[TBL] [Abstract][Full Text] [Related]
3. RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.
Martucciello S; Lavric M; Toth B; Korponay-Szabo I; Nadalutti C; Myrsky E; Rauhavirta T; Esposito C; Sulic AM; Sblattero D; Marzari R; Mäki M; Kaukinen K; Lindfors K; Caja S
J Mol Med (Berl); 2012 Jul; 90(7):817-26. PubMed ID: 22223195
[TBL] [Abstract][Full Text] [Related]
4. Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.
Myrsky E; Caja S; Simon-Vecsei Z; Korponay-Szabo IR; Nadalutti C; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Cell Mol Life Sci; 2009 Oct; 66(20):3375-85. PubMed ID: 19680746
[TBL] [Abstract][Full Text] [Related]
5. Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb angiogenesis.
Myrsky E; Kaukinen K; Syrjänen M; Korponay-Szabó IR; Mäki M; Lindfors K
Clin Exp Immunol; 2008 Apr; 152(1):111-9. PubMed ID: 18279443
[TBL] [Abstract][Full Text] [Related]
6. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
7. Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.
Kalliokoski S; Sulic AM; Korponay-Szabó IR; Szondy Z; Frias R; Perez MA; Martucciello S; Roivainen A; Pelliniemi LJ; Esposito C; Griffin M; Sblattero D; Mäki M; Kaukinen K; Lindfors K; Caja S
PLoS One; 2013; 8(6):e65887. PubMed ID: 23824706
[TBL] [Abstract][Full Text] [Related]
8. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
9. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions.
Di Niro R; Mesin L; Zheng NY; Stamnaes J; Morrissey M; Lee JH; Huang M; Iversen R; du Pré MF; Qiao SW; Lundin KE; Wilson PC; Sollid LM
Nat Med; 2012 Feb; 18(3):441-5. PubMed ID: 22366952
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase in celiac disease: role of autoantibodies.
Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against neo-epitope of microbial and human transglutaminase complexes as biomarkers of childhood celiac disease.
Agardh D; Matthias T; Wusterhausen P; Neidhöfer S; Heller A; Lerner A
Clin Exp Immunol; 2020 Mar; 199(3):294-302. PubMed ID: 31663117
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease].
Fernández ML; Vivas S; Ruiz de Morales JM; Marugán JM
Gastroenterol Hepatol; 2005 Oct; 28(8):437-40. PubMed ID: 16185576
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against soluble and immobilized human recombinant tissue transglutaminase in children with celiac disease.
Agardh D; Dahlbom I; Daniels T; Lörinc E; Ivarsson SA; Lernmark A; Hansson T
J Pediatr Gastroenterol Nutr; 2005 Sep; 41(3):322-7. PubMed ID: 16131987
[TBL] [Abstract][Full Text] [Related]
18. Generation of circulating autoreactive pre-plasma cells fueled by naive B cells in celiac disease.
Lindeman I; Høydahl LS; Christophersen A; Risnes LF; Jahnsen J; Lundin KEA; Sollid LM; Iversen R
Cell Rep; 2024 Apr; 43(4):114045. PubMed ID: 38578826
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
20. Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies.
Elitsur Y; Sigman T; Watkins R; Porto AF; Leonard Puppa EL; Foglio EJ; Preston DL
Dig Dis Sci; 2017 Jan; 62(1):175-179. PubMed ID: 27778203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
